![]() |
|
|
Vol. 280, Issue 3, 1423-1431, 1997
Neurofarmacología, Instituto de Neurobiología
Santiago Ramón y Cajal, Consejo Superior de Investigaciones
Científicas, 28002 Madrid, Spain
Repeated intracerebroventricular injections of antisense
oligodeoxynucleotides (ODNs) were used to selectively restrict the expression of cloned mu and delta opioid
receptors (OR) in the mouse brain. Reduction of mu and
delta OR-like immunoreactivity was observed in brain
structures of experimental mice. A random-sequence ODN used as a
control showed no effect. ODNs to OR decreased radiolabeling of neural
structures after intracerebroventricular injection of 125I-immunoglobulins G directed to mu
or delta OR. The potencies of opioids binding the
mu OR,
[D-Ala2,N-MePhe4,Gly-ol5]enkephalin
and morphine were significantly attenuated in mice injected with ODNs
to this receptor, an effect not seen for the delta
OR-binding agonists, [D-Pen2,5]enkephalin and
[D-Ala2]deltorphin II. In morphine-dependent
mice, ODNs to mu OR reduced the incidence of
naloxone-precipitated withdrawal jumping, body weight loss and
diarrhea. The ODN directed to nucleotides 7-26 of the
delta OR mRNA selectively impaired antinociception
induced by [D-Ala2]deltorphin II
(delta-2), but not that of
[D-Pen2,5]enkephalin (delta-1) or
morphine. It also diminished the incidence of withdrawal signs
precipitated by naloxone in morphine-dependent mice. Thus, the cloned
mu OR mediates morphine-evoked antinociception as well
as physical dependence. The involvement of delta-2 OR in
the development and/or expression of morphine dependence is suggested.
This article has been cited by other articles:
![]() |
D. J. Daniels, N. R. Lenard, C. L. Etienne, P.-Y. Law, S. C. Roerig, and P. S. Portoghese Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series PNAS, December 27, 2005; 102(52): 19208 - 19213. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Walwyn, N. T. Maidment, M. Sanders, C. J. Evans, B. L. Kieffer, and T. G. Hales Induction of {delta} Opioid Receptor Function by Up-Regulation of Membrane Receptors in Mouse Primary Afferent Neurons Mol. Pharmacol., December 1, 2005; 68(6): 1688 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fan, G. Varghese, T. Nguyen, R. Tse, B. F. O'Dowd, and S. R. George A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of {micro} and {delta} Opioid Receptor Hetero-oligomers J. Biol. Chem., November 18, 2005; 280(46): 38478 - 38488. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Prinster, C. Hague, and R. A. Hall Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gomes, A. Gupta, J. Filipovska, H. H. Szeto, J. E. Pintar, and L. A. Devi A role for heterodimerization of {micro} and {delta} opiate receptors in enhancing morphine analgesia PNAS, April 6, 2004; 101(14): 5135 - 5139. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pol, J. R. Palacio, and M. M. Puig The Expression of {delta}- and {kappa}-Opioid Receptor Is Enhanced during Intestinal Inflammation in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Charles, N. Mostovskaya, K. Asas, C. J. Evans, M. L. Dankovich, and T. G. Hales Coexpression of delta -Opioid Receptors with {micro} Receptors in GH3 Cells Changes the Functional Response to {micro} Agonists from Inhibitory to Excitatory Mol. Pharmacol., January 1, 2003; 63(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pol, F. Alameda, and M. M. Puig Inflammation Enhances {micro}-Opioid Receptor Transcription and Expression in Mice Intestine Mol. Pharmacol., November 1, 2001; 60(5): 894 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Sunday, K. J. Haley, R. L. Emanuel, J. S. Torday, N. Asokananthan, K. A. Sikorski, I. Tooyama, H. Kimura, T. Renda, and V. Erspamer Fetal Alveolar Epithelial Cells Contain [D-Ala2]-Deltorphin I-like Immunoreactivity . delta - and {micro}-Opiate Receptors Mediate Opposite Effects in Developing Lung Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sánchez-Blázquez and J. Garzón Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 820 - 827. [Abstract] [Full Text] |
||||
![]() |
I. Gomes, B. A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L. A. Devi Heterodimerization of {micro} and delta Opioid Receptors: A Role in Opiate Synergy J. Neurosci., November 15, 2000; 20(22): RC110 - RC110. [Abstract] [Full Text] [PDF] |
||||